Glutamate receptors as therapeutic targets

被引：0
|
作者：
Javitt D.C. [1 ]
机构：
[1] Nathan Kline Inst. Psychiat. Res., New York Univ. School of Medicine
来源：
Molecular Psychiatry | 2004年 / 9卷 / 11期
关键词：
D O I：
10.1038/sj.mp.4001602
中图分类号：
学科分类号：
摘要：
[No abstract available]
引用
收藏
页码：979 / 979
相关论文
共 50 条
  • [1] Glutamate metabotropic receptors as therapeutic targets in epilepsy
    Meldrum, BS
    Conn, PJ
    Merlin, LR
    Shinnick-Gallagher, P
    Chapman, AG
    EPILEPSIA, 1999, 40 : 1 - 1
  • [2] Glutamate and Its Receptors as Therapeutic Targets for Migraine
    Jan Hoffmann
    Andrew Charles
    Neurotherapeutics, 2018, 15 : 361 - 370
  • [3] Ionotropic Glutamate Receptors as Therapeutic Targets in Schizophrenia
    Coyle, Joseph T.
    Tsai, Guochuan
    Goff, Donald C.
    CNS & NEUROLOGICAL DISORDERS-DRUG TARGETS, 2002, 1 (02) : 183 - 189
  • [4] Glutamate and Its Receptors as Therapeutic Targets for Migraine
    Hoffmann, Jan
    Charles, Andrew
    NEUROTHERAPEUTICS, 2018, 15 (02) : 361 - 370
  • [5] Metabotropic glutamate receptors as therapeutic targets for schizophrenia
    Vinson, Paige N.
    Conn, P. Jeffrey
    NEUROPHARMACOLOGY, 2012, 62 (03) : 1461 - 1472
  • [6] GABA AND GLUTAMATE RECEPTORS AS THERAPEUTIC TARGETS IN NEURODEGENERATIVE DISORDERS
    KROGSGAARDLARSEN, P
    PHARMACOLOGY & TOXICOLOGY, 1992, 70 (02): : 95 - 104
  • [7] Metabotropic Glutamate Receptors as Therapeutic Targets for Cognitive Disorders
    Gravius, A.
    Pietraszek, M.
    Dekundy, A.
    Danysz, W.
    CURRENT TOPICS IN MEDICINAL CHEMISTRY, 2010, 10 (02) : 187 - 206
  • [8] Glutamate Receptors as Therapeutic Targets for Parkinson's Disease
    Johnson, Kari A.
    Conn, P. Jeffrey
    Niswender, Colleen M.
    CNS & NEUROLOGICAL DISORDERS-DRUG TARGETS, 2009, 8 (06) : 475 - 491
  • [9] Metabotropic glutamate receptors as therapeutic targets in epilepsy.
    Meldrum, BS
    BRITISH JOURNAL OF PHARMACOLOGY, 2000, 131
  • [10] Metabotropic glutamate receptors as therapeutic targets in Parkinson's disease
    Reynolds, I. J.
    NEUROPHARMACOLOGY, 2008, 55 (04) : 620 - 621
12345